Africa: Covid-19 – Local Researchers Welcome Sputnik V Vaccine Findings

[spotlight] Local researchers have welcomed findings for Russia’s Sputnik V viral vector vaccine, which achieved efficacy of 91.6% in preventing symptomatic COVID-19 in a large Phase 3 clinical trial. They say it is a boost to global efforts to control the pandemic.

Leave a Reply